Lower Saxony promotes its biotech credentials
This article was originally published in Clinica
Executive Summary
The German federal state of Lower Saxony is a success story for biotechnology companies in Germany, says Lower Saxony president Sigmar Gabriel. Speaking last week at the 4th biotechnology conference of the federal ministry of education and research (BMBF) in Braunschweig, Mr Gabriel said that the German lower house's (Bundestag's) decision to allow stem cell research (see Clinica No 1006, p 5) was a step in the right direction, but that the country needed to go further still. "It is no longer a question of whether we decide to use this 'cross-sectional' technology, but how we become a worldwide competitor in this field," he said.